AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Bofinger, DP Feng, L Chi, LH Love, J Stephen, FD Sutter, TR Osteen, KG Costich, TG Batt, RE Koury, ST Olson, JR
Citation: Dp. Bofinger et al., Effect of TCDD exposure on CYP1A1 and CYP1B1 expression in explant cultures of human endometrium, TOXICOL SCI, 62(2), 2001, pp. 299-314

Authors: Kwak, MK Itoh, K Yamamoto, M Sutter, TR Kensler, TW
Citation: Mk. Kwak et al., Role of transcription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1,2-dithiole-3-thione, MOL MED, 7(2), 2001, pp. 135-145

Authors: Guengerich, FP Cai, HL McMahon, M Hayes, JD Sutter, TR Groopman, JD Deng, ZW Harris, TM
Citation: Fp. Guengerich et al., Reduction of aflatoxin B-1 dialdehyde by rat and human aldo-keto reductases, CHEM RES T, 14(6), 2001, pp. 727-737

Authors: Hudson, CE Schulte, BA Sutter, TR Norris, JS
Citation: Ce. Hudson et al., Steroid hormones modulate expression of cytochrome P450 enzymes in male hamster reproductive tract and leiomyosarcomas, CARCINOGENE, 22(5), 2001, pp. 763-770

Authors: Dick, RA Kwak, MK Sutter, TR Kensler, TW
Citation: Ra. Dick et al., Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase - A new role for leukotriene B-4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase, J BIOL CHEM, 276(44), 2001, pp. 40803-40810

Authors: Spencer, DL Masten, SA Lanier, KM Yang, XP Grassman, JA Miller, CR Sutter, TR Lucier, GW Walker, NJ
Citation: Dl. Spencer et al., Quantitative analysis of constitutive and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1B1 expression in human lymphocytes, CANC EPID B, 8(2), 1999, pp. 139-146

Authors: Shimada, T Gillam, EMJ Oda, Y Tsumura, F Sutter, TR Guengerich, FP Inoue, K
Citation: T. Shimada et al., Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene by recombinant human cytochrome P4501B1 and purified liver epoxide hydrolase, CHEM RES T, 12(7), 1999, pp. 623-629

Authors: Kensler, TW Groopman, JD Sutter, TR Curphey, TJ Roebuck, BD
Citation: Tw. Kensler et al., Development of cancer chemopreventive agents: Oltipraz as a paradigm, CHEM RES T, 12(2), 1999, pp. 113-126

Authors: Shimada, T Watanabe, J Kawajiri, K Sutter, TR Guengerich, FP Gillam, EMJ Inoue, K
Citation: T. Shimada et al., Catalytic properties of polymorphic human cytochrome P4501B1 variants, CARCINOGENE, 20(8), 1999, pp. 1607-1613

Authors: Knight, LP Primiano, T Groopman, JD Kensler, TW Sutter, TR
Citation: Lp. Knight et al., cDNA cloning, expression and activity of a second human aflatoxin B-1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3, CARCINOGENE, 20(7), 1999, pp. 1215-1223

Authors: Kim, JH Stansbury, KH Walker, NJ Trush, MA Strickland, PT Sutter, TR
Citation: Jh. Kim et al., Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P4501B1 (vol 19, pg 1847, 1998), CARCINOGENE, 20(3), 1999, pp. 515-515

Authors: Starr, TB Greenlee, WF Neal, RA Poland, A Sutter, TR
Citation: Tb. Starr et al., The trouble with TEFs, ENVIR H PER, 107(10), 1999, pp. A492-A493

Authors: Walker, NJ Portier, CJ Lax, SF Crofts, FG Li, Y Lucier, GW Sutter, TR
Citation: Nj. Walker et al., Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in theliver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin, TOX APPL PH, 154(3), 1999, pp. 279-286

Authors: Pang, SK Cao, JQ Katz, BH Hayes, CL Sutter, TR Spink, DC
Citation: Sk. Pang et al., Inductive and inhibitory effects of non-ortho-substituted polychlorinated biphenyls on estrogen metabolism and human cytochromes P450 1A1 and 1B1, BIOCH PHARM, 58(1), 1999, pp. 29-38
Risultati: 1-14 |